Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation.
Giulia Di FrancescoFilippo CieriRoberto EspositoPierpaola SciarraValeria BallariniMauro Di IanniStella SantaronePublished in: Journal of clinical medicine (2023)
Our findings indicate that QoL is a concurrent causative factor to the development of PTSD symptomatology through the mediating role of fatigue. Innovative interventions before transplantation to prevent PTSD symptoms should be investigated to improve survival and QoL in patients.
Keyphrases
- allogeneic hematopoietic stem cell transplantation
- sleep quality
- posttraumatic stress disorder
- social support
- ejection fraction
- newly diagnosed
- acute lymphoblastic leukemia
- acute myeloid leukemia
- squamous cell carcinoma
- prognostic factors
- stem cells
- depressive symptoms
- bone marrow
- mass spectrometry
- single molecule
- patient reported